Atlas Trials

Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU

Clinical trial NCT05833282 · UNKNOWN

Trial details

NCT number
NCT05833282
Sponsor
Tourcoing Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Drug Resistance, Multiple, Bacterial
Start date
2022-07-01
Primary completion
2023-06-30
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.